Page last updated: 2024-08-22

tranylcypromine and Glioblastoma

tranylcypromine has been researched along with Glioblastoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mielke, D; Ninkovic, M; Rohde, V; Sachkova, A; Schatlo, B; Sperling, S1
Ambrosio, S; Amente, S; Faicchia, D; Gorini, F; Lania, L; Majello, B; Matarese, G; Saccà, CD1
Barton, M; Chandra, J; Flores, ER; Johnson, B; Lang, F; Singh, MM; Su, X; Venkatarayan, A; Zhang, J1
Bielecka, AM; Obuchowicz, E1
Aldape, K; Barton, MC; Bhat, KP; Chandra, J; Manton, CA; Singh, MM; Tsai, WW1

Other Studies

5 other study(ies) available for tranylcypromine and Glioblastoma

ArticleYear
Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.
    Anticancer research, 2019, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Riluzole; Temozolomide; Tranylcypromine; Valproic Acid; Xenograft Model Antitumor Assays

2019
Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
    Biochimica et biophysica acta. Gene regulatory mechanisms, 2019, Volume: 1862, Issue:5

    Topics: Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cellular Senescence; Enzyme Inhibitors; Glioblastoma; Histone Demethylases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mechanistic Target of Rapamycin Complex 1; Mitochondria; Tranylcypromine

2019
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
    Neuro-oncology, 2015, Volume: 17, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Female; Glioblastoma; High-Throughput Nucleotide Sequencing; Histone Deacetylase Inhibitors; Histone Demethylases; Humans; Hydroxamic Acids; Immunoblotting; Mice; Mice, Nude; Neoplastic Stem Cells; Polymerase Chain Reaction; Transcriptome; Tranylcypromine; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays

2015
Antidepressant drugs can modify cytotoxic action of temozolomide.
    European journal of cancer care, 2017, Volume: 26, Issue:5

    Topics: Antidepressive Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Dacarbazine; Depression; Drug Interactions; Fluoxetine; Glioblastoma; Humans; Imipramine; Temozolomide; Tranylcypromine; Tumor Hypoxia

2017
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Neuro-oncology, 2011, Volume: 13, Issue:8

    Topics: Acetylation; Astrocytes; Blotting, Western; Brain Neoplasms; Caspases; Cells, Cultured; DNA Methylation; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Monoamine Oxidase Inhibitors; Neoplastic Stem Cells; Neural Stem Cells; RNA, Small Interfering; Tranylcypromine; Vorinostat

2011